Academic Research

Strainprint’s mission is to advance the scientific understanding of cannabis for medical and therapeutic uses. If you are an academic researcher looking to access Strainprint’s rich patient data for non-commercial research and peer-reviewed publication.

Journal of Pain (Vol. 20, Number 12 / Dec. 2019)

The use of cannabis to alleviate headache and migraine is relatively common, yet research on its effectiveness remains sparse. We sought to determine whether inhalation of cannabis decreases headache and migraine ratings as well as whether gender, type of cannabis (concentrate vs. flower), THC, CBD, or dose contribute to changes in these ratings. Finally, we explored evidence for tolerance to these effects.

Journal of Palliative Medicine (Vol. 22, Issue 10 / Oct. 2019)

To determine the relative contributions of tetrahydrocannabinol (THC) and cannabidiol (CBD) to patients' self-ratings of efficacy for common palliative care symptoms.

Design: This is an electronic record-based retrospective cohort study. Model development used logistic regression with bootstrapped confidence intervals (CIs), with standard errors clustered to account for multiple observations by each patient.

 

Journal of Affective Disorders (Volume 235, 1 August 2018, Pages 198-205)

Cannabis is commonly used to alleviate symptoms of negative affect. However, a paucity of research has examined the acute effects of cannabis on negative affect in everyday life. The current study provides a naturalistic account of perceived changes in symptoms of depression, anxiety, and stress as a function of dose and concentration of Δ9tetrahydrocannabinol (THC) and cannabidiol (CBD).

Can't find what you're looking for?

Contact us about our custom research, specifically tailored to your individual needs.